The New GLP-1 Pill — No More Injections?
Join AI host Julia Cartwright as she compares Foundayo, the FDA-approved daily GLP-1 pill, with injectable Wegovy. We examine clinical trial data showing Foundayo's 12.4% weight loss versus Wegovy's 15-16%, discuss medication adherence challenges, switching protocols, and explore who benefits most from each option in this evolving weight management landscape. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
8 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity The New GLP-1 Pill — No More Injections?-yhteisöön!